S_1114_1 CG
Cancer research

Tumor Microenvironment Analysis using NGS Workflows

Getting to grips with the tumor microenvironment with NGS workflows

Tumor microenvironment (TME) analysis is a key focus in cancer research as the TME plays a critical role in cancer development, growth and spread. The TME is made up of a complex network of cells, molecules and blood vessels surrounding a tumor. High heterogeneity within the TME remains a key obstacle in tumor profiling and understanding cancer. Due to its dynamic nature, tumor microenvironment analysis requires highly sensitive technologies to detect its specific components. NGS, with its sheer discovery power and ability to capture intricate genomic and transcriptomic details, is your best shot at deciphering the multiple molecular interactions within the TME, such as:

  • Revealing and profiling rare DNA variants, CNVs and methylation patterns
  • Investigating differential gene expression profiles between healthy and tumor tissue
  • Analyzing the expression of lncRNAs and miRNAs to shed light on their roles as mediators of cell signaling regulation
  • Assessing the comprehensive TCR repertoire to understand the immune response in the TME
  • Achieving a holistic view of DNA and RNA with multiomic profiling
  • Evaluating microbial diversity and its impact on the TME

TME components

Getting acquainted with the multiple players that make up the TME.
Tumor cells
Tumor profiling
Discover genomic variants, differential gene expression signatures or simultaneously profile DNA and RNA from the same sample
Immune cells
Immune response analysis
Characterize and quantify the immune response and T-cell repertoires
Stromal cells
Stromal cell characterization
Identify gene expression profiles of specific stromal cell subtypes to understand their contribution to the hallmarks of cancer
Microbiome
Microbial profiling
Explore the influence of the tissue and stool microbiome
Best-practice workflows for challenging FFPE, low-input and other complex samples
Whether you’re working with FFPE samples, RNA of variable input and quality or complex microbiome samples, our expert resources, optimized technologies and best practices set the foundations for success in TME analysis.
Experiences with targeted sequencing
Dr. Barnaby Clark, Laboratory Lead for Precision Medicine at Kings College Hospital NHS Foundation Trust, discusses his experiences with targeted sequencing and, ultimately, the choice of NGS panels for his projects.
Driving insights into pancreatic cancer risk using custom NGS panels
Dr. Fergus Couch from the Mayo Clinic discusses how QIAseq Targeted DNA Panels played a vital role in a longitudinal case-control study on the risk of pancreatic cancer.
Person in a lab coat pointing at monitor screen
Context is everything when it comes to analyzing and interpreting the molecular interactions within the TME. From studying differential gene expression and uncovering pathway insights to detecting low-frequency variants, explore our biologist-friendly NGS data analysis and interpretation tools.